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Abstract: In order to assess the efficacy of epidural steroid injections (ESI) in acute and subacute pain due to lumbar 
spine disk herniation, we conducted a randomized trial, comparing 2 different protocols. Fourty patients with radicular 
pain due to L4-L5 and L5-S1 disc herniation were assigned to receive either 3 consecutive ESI every 24 hours through a 
spinal catheter (group A) or 3 consecutive ESI every 10 days with an epidural needle (group B). All patients had improved 
Oswestry Disabilty Index (ODI) and the Visual Analog Scale (VAS) for pain scores at 1 month of follow-up compared to 
baseline, while no significant differences were observed between the 2 groups. The scores for group B were statistically 
significant lower at 2 months of follow-up compared to those of group A. The improvement in the scores of group B was 
continuous since the mean scores at 2 months of follow up were lower compared to the respective scores at 1 month. 
Protocol B (3 consecutive ESI every 10 days) was found more effective in the treatment of subacute pain compared to 
Protocol A (3 consecutive ESI every 24 hours) with statistically significant differences in the ODI and VAS scores at 2 
months of follow-up. 
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INTRODUCTION 
  Low back pain and radicular pain is a socioeconomic 
problem of huge significance, affecting all age groups and 
economic classes. More than 70% of people in developed 
countries will experience low back pain at least once in their 
lives [1]. Disc herniation and spinal canal stenosis are the 
most common causes of low back pain. Particularly in the 
case of disc herniation, the pathophysiology of pain 
development involves not only a mechanical effect from the 
compression of the nerve root by protruded disk but the 
implication of inflammation around and within the 
compressed nerve root as well [2, 3]. Based on this 
inflammatory involvement, epidural steroid injections (ESI) 
have been extensively used with controversial results [4-16]. 
ESI can be accomplished by one of the following 
approaches; caudal, interlaminar or transforaminal. The aim 
of the present study was to assess the efficacy of 2 different 
protocols of interlaminar ESI in acute and subacute pain of 
the lumbar spine through a randomized comparison. 
MATERIALS AND METHODOLOGY 
  Forty patients with a mean age of 52.4 years (range 28-
60) and predominant radicular pain due to a lumbar spine 
herniated disc were prospectively randomized to 2 ESI   
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protocols. We had 22 males and 18 females. The 
randomization was performed using random number tables. 
A detailed explanation of the type of the procedure and the 
possible side effects and complications were given to each 
patient. Written informed consent was obtained from patients 
before inclusion in the study. All patients had radicular pain 
due to L4-L5 and L5-S1 disc herniation that was 
documented with Magnetic Resonance Imaging (MRI) and 
electromyographic examination. Patients with extruded discs 
and stenosis of the spinal canal were excluded from the 
study. All patients had positive straight leg raising test and 
no patient had any neurological deficit. All of them had 
previously received conservative treatment for a period of 4 -
6 weeks. Treatment was the same in both groups and 
consisted of a non-steroidal anti-inflammatory drug 
(diclofenac 100mg/day divided at 2 doses/day) and a muscle 
relaxant (thiocolchicoside 12mg/day divided at 3 doses/day). 
Despite conservative treatment patients had no improvement 
of the clinical presentation and all denied the proposed 
surgical intervention. No patient received any medication 
[analgesics, Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs)] for the radicular pain within the previous 2 
weeks before inclusion in the study protocols and during the 
protocol. Exclusion criteria were bleeding history, use of 
anticoagulants, known allergy to any of the components of 
the epidural injection, previous lumbar spinal surgery, 
radiologically proven facet syndrome and lumbar instability, 
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pregnancy. The institutional review board of the University 
Hospital of Ioannina approved the study. 
  Patients were assigned to 2 protocols. According to the 
first protocol (Protocol A) patients received the medication 
through an epidural catheter placed at the L3-L4 level with 
an interlaminar approach and a caudal orientation. The 
patients in this protocol had 3 consecutive ESI every 24 
hours through the catheter. In the second protocol (Protocol 
B) patients had 3 consecutive ESI every 10 days with an 18-
gauge epidural needle through an interlaminar approach at 
the L3-L4 level and a caudal orientation as well. All 
injections were performed by the same anesthetist blinded to 
patient’s protocol. Fluoroscopic guidance was used in both 
groups to ensure correct placement of the needle and thus 
enhance the safety of the procedure. The medication used in 
each ESI was the same in both protocols and included (3+3) 
mg of betamethasone acetate and betamethasone as sodium 
phosphate, 150mg clonidine and 5ml of 2% ropivacaine 
hydrochloride diluted with NaCl 0.9% till an overall volume 
of 10ml was achieved. All patients followed the same 
rehabilitation program that included restriction of their 
outdoor daily activities for 4 weeks after treatment, as they 
were allowed to indoor and outdoor activities after that 
period without being involved in their occupation (work). 
  Patients were evaluated before ESI and at 1 and 2 months 
after the last injection with the greek version of the Oswestry 
Disabilty Index (ODI) [17] and pain was estimated using a 
Visual Analog Scale for pain (VAS). Side effects from ESI 
were recorded. The evaluation of each patient was performed 
by an independent investigator blinded to the type of ESI 
that the patients received. A t test for independent samples 
was used to determine whether there was a significant 
difference in mean values of the pain scores or not. P < 0.05 
was considered formally statistically significant; all p-values 
were two tailed. All statistical analyses were performed 
using the Statistical Package for Social Sciences (SPSS 16.0 
Inc., Chicago, IL, USA). 
RESULTS 
  No patient reported any treatment-related side effect 
either acute or during the 2-month follow-up period. The 
outcomes are represented in Figs. (1,  2). No statistically 
significant differences were observed in the baseline scores 
between the 2 groups. The mean (SD) baseline ODI value 
before ESI was 54.8 (11.7) for patients in A group, while the 
respective score for patients in group B was 53.8 (6.3). The 
mean baseline VAS values were 7.0 (1.5) and 6.45 (0.8) for 
patients in A and B group respectively. 
  All patients had improved scores at 1 month of follow-up 
compared to the scores before ESI. Patients enrolled in 
protocol B had lower ODI values [mean (SD) value of 31.4 
(7.2)] compared to patients enrolled in protocol A [mean 
(SD) value of 37.9 (16.5), but the difference was not 
statistically significant (p = 0.18). The VAS values were 
similar in the 2 groups at 1 month of follow up [mean (SD) 
values of 5.1 (0.8) and 5.6 (1.7) in groups A and B 
respectively]. 
  At 2 months patients that had 3 consecutive ESI every 10 
days (group B) had statistically significant lower scores than 
patients that had 3 consecutive ESI every 24 hours through a 
catheter (group A). The mean (SD) ODI value was 25.4 
(13.3) for group B and 44.2 (14.6) for group A, with a p 
value of 0.01 for the comparison between the 2 groups. 
Finally, the mean (SD) VAS value was 3.9 (1.4) for group B 
and 5.9 (2.1) for group A and the difference was also highly 
statistically significant (p = 0.01). 
DISCUSSION 
  Lumbar epidural steroid injections is one of the most 
commonly performed interventional procedures for 
managing back and leg pain, sometimes used as the final 
 
Fig. (1). ODI values for protocols A and B. 
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non-surgical treatment modality before surgical intervention 
[4, 6, 7, 10, 11, 14]. Indications for lumbar epidural injections 
include low back pain associated with radicular symptoms, 
failure of medications, therapy and rest with persistence of 
functionally limiting back and leg pain beyond 6 weeks, 
advanced imaging studies demonstrating nerve root 
compression with clinical correlation or physical 
examination findings consistent with nerve root irritation (ie, 
positive dural tension signs and/or evidence of neurologic 
deficits). Contraindications are divided into absolute, such as 
the use of anticoagulants or the presence of coagulopathy, an 
active local or systemic infection and uncontrolled diabetes 
or spinal malignancy and into relative such as allergy to 
injectate, history of steroid psychosis, congestive heart 
failure, pregnancy or history of failed epidural injection [16]. 
  The underlying mechanism of action of epidurally 
administered local anesthetic and steroid injections is not 
well understood. Multiple hypotheses have been presented. 
The effect is believed to result from interruption of the pain-
spasm cycle and nociceptor transmission by the local 
analgesic and by reduced inflammation induced by the 
corticosteroids. Corticosteroids stabilize cell membranes, 
inhibit neural peptide synthesis and action, suppress neuronal 
discharge and suppress sensitization of dorsal horn neurons, 
while local anesthetics dampen C-fiber activity [18-27]. 
  Five randomized trials related to lumbar interlaminar 
procedures that study patients with disc herniation and 
radiculitis exist in the literature [12]. Arden et al. [5] studied 
228 patients with unilateral sciatica. Patients were assigned 
to receive either 80 mg of triamcinolone acetonide and 10ml 
of bupivacaine at 3 doses (weeks 0, 3 and 6) or placebo 
injections of 2ml of normal saline. Patients in the 
experimental group showed statistically significant 
improvement in function over placebo in 3 weeks, but this 
benefit was lost in 6 weeks. Wilson-MacDonald et al. [15] 
examined 93 patients with MRI evidence of a disc prolapsed, 
spinal stenosis or a combination. The experimental group 
underwent an epidural injection of 40mg bupivacaine 0.5% 
with 80mg of methylprednisolone, while the control group 
an intramuscular injection of 40mg bupivacaine 0.5% with 
80mg of methylprednisolone. Patients in the experimental 
group showed a useful improvement in nerve root 
symptoms. Long-term relief was negative. Carette et al. [8] 
included 158 patients with sciatica due to herniated nucleus 
pulposus. The treatment group was injected with 80mg of 
methylprednisolone acetate and 8mg of isotonic saline, while 
the control group with 1ml isotonic saline. Both groups 
underwent 3 epidural injections 3 weeks apart. Significant 
improvement was seen in leg pain in the methylprednisolone 
group after 6 weeks with no difference after 3 and 12 
months. Cuckler et al. [9] examined 73 patients with a 
clinical diagnosis of either acute herniated nucleus pulposus 
or spinal stenosis. The experimental group was given 80mg 
of methylprednisolone and 5 ml of procaine 1%, while the 
control group was given 2ml saline and 5ml of procaine 1%. 
No significant short or long-term improvements were 
notable between the two groups. Finally, Snoek et al. [28] 
included 51 patients with lumbar root compression 
documented by neurological deficit and a concordant 
abnormality noted on myelography. The treatment group was 
injected with 80mg of methylprednisolone, whereas the 
control group with 2ml of normal saline. No significant 
differences were noted in either group. 
  The present prospective randomized study represents the 
only available up-to-date study that compares one group 
treated with 3 consecutive ESI every 24 hours with another 
treated with 3 consecutive ESI every 10 days. Based on the 
results of our study, ESI were proved to be effective 
regarding the improvement of ODI and VAS scores in 
patients with predominant acute and subacute radicular pain 
Fig. (2). VAS values for protocols A and B. 
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due to lumbar spine herniated disks regardless of the 
protocol patients were assigned to. However, the scores for 
patients that had 3 consecutive ESI every 10 days were 
statistically significant lower at 2 months of follow-up 
compared to those that had 3 consecutive days ESI through a 
catheter. The improvement in the scores of group B patients 
was continuous since the mean scores at 2 months of follow 
up were lower compared to the respective scores at 1 month. 
  Some limitations of the present study should be 
acknowledged. First of all, it was a study that was limited to 
sample size. Other limitations include the small duration of 
follow-up and the absence of a control group. Another 
limitation is the possible source of bias resulting from the 
fact that all enrolled patients were those who rejected the 
surgery. It is unknown whether the reported results would be 
reproduced if patients that did not exclude a surgical 
procedure as a solution to their problem were included in the 
study. However, no statistically significant differences were 
observed in the baseline scores between the 2 groups. 
CONCLUSION 
  The efficacy of 2 different protocols of interlaminar ESI 
in acute and subacute pain was assessed. All patients had 
improved scores at 1 month follow-up, with no significant 
differences between the 2 groups, whereas patients that had 3 
consecutive ESI every 10 days showed significant lower 
scores at 2 months of follow-up with continuous 
improvement of their clinical condition. 
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